APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2024 FINANCIAL RESULTS ON MARCH 13, 2025ApyxMedical2025-12-12T17:55:01+00:00February 28, 2025|Read More
APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2024 REVENUE RESULTSApyxMedical2025-12-12T17:55:32+00:00January 13, 2025|Read More
APYX MEDICAL CORPORATION SUBMITS 510(K) PREMARKET NOTIFICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION FOR THE AYON BODY CONTOURING SYSTEM™ApyxMedical2025-12-12T17:55:58+00:00January 6, 2025|Read More
APYX MEDICAL CORPORATION TO PARTICIPATE IN THE PIPER SANDLER 36TH ANNUAL HEALTHCARE CONFERENCEApyxMedical2025-12-12T17:56:25+00:00December 2, 2024|Read More
APYX MEDICAL CORPORATION ANNOUNCES $7,000,000 MILLION REGISTERED DIRECT OFFERINGApyxMedical2025-12-12T17:56:54+00:00November 8, 2024|Read More
Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial OutlookApyxMedical2025-12-12T17:57:22+00:00November 7, 2024|Read More
APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON NOVEMBER 8, 2024ApyxMedical2025-12-12T17:57:48+00:00October 24, 2024|Read More
RENUVION NAMED #1 TRUSTED BODY CONTOURING TECHNOLOGY BY DOCTORS*ApyxMedical2025-12-12T17:58:14+00:00August 13, 2024|Read More
APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION COMPARING THE USE OF RENUVION TO A COMPETING TECHNOLOGY FOLLOWING LIPOSUCTION OR BODY CONTOURING PROCEDURESApyxMedical2025-12-12T17:58:38+00:00August 8, 2024|Read More
APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS; UPDATES FULL YEAR 2024 FINANCIAL OUTLOOKApyxMedical2025-12-12T17:59:34+00:00August 8, 2024|Read More
APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON AUGUST 8, 2024ApyxMedical2025-12-12T18:01:36+00:00July 25, 2024|Read More
APYX MEDICAL CORPORATION LAUNCHES THE “RENEWING LIVES” GIVE-BACK CAMPAIGN PROVIDING TREATMENTS WITH RENUVION TO BENEFIT PHYSICAL APPEARANCE AND MENTAL HEALTHApyxMedical2025-12-12T18:03:58+00:00June 26, 2024|Read More
APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS; REAFFIRMS FULL YEAR 2024 FINANCIAL OUTLOOKApyxMedical2025-12-12T18:04:30+00:00May 9, 2024|Read More
APYX MEDICAL CORPORATION ANNOUNCES BOARD LEADERSHIP TRANSITIONApyxMedical2025-12-12T18:04:59+00:00May 9, 2024|Read More
APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON MAY 9, 2024ApyxMedical2025-12-12T18:05:38+00:00April 25, 2024|Read More
APYX MEDICAL CORPORATION SHOWCASES NEW DATA AND TREATMENT INSIGHTS AT THE RENUVION USERS’ SUMMITApyxMedical2025-12-12T18:06:03+00:00April 11, 2024|Read More
